# OnCo record blz-100 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/blz-100/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "blz-100" ;
  schema:name "Tozuleristide"@en ;
  schema:alternateName "BLZ-100"@en, "Tumor Paint"@en ;
  schema:description "Tozuleristide is an experimental fluorescent imaging agent from Blaze Bioscience, in phase 3 trials for paediatric central nervous system tumours, breast cancer and glioma and other cancers."@en ;
  schema:url <https://onco.cc/drugs/blz-100/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.blazebioscience.com/technology/>, <http://www.blazebioscience.com>, <http://www.blazebioscience.com>, <https://clinicaltrials.gov/search?intr=BLZ-100> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Fluorescent imaging agent (chlorotoxin-derived peptide conjugated to a near-infrared dye)" ;
  onco:cancers <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/skin-cancer/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:companies <https://onco.cc/companies/blaze-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct03579602/>, <https://onco.cc/trials/nct02462629/>, <https://onco.cc/trials/nct02234297/>, <https://onco.cc/trials/nct02496065/>, <https://onco.cc/trials/nct02097875/>, <https://onco.cc/trials/nct05316688/>, <https://onco.cc/trials/nct02464332/>, <https://onco.cc/trials/nct04343274/> .